KOR

e-Article

The therapeutic efficacy of adenoviral vectors for cancer gene therapy is limited by a low level of primary adenovirus receptors on tumour cells
Document Type
Article
Source
In European Journal of Cancer 2002 38(14):1917-1926
Subject
Language
ISSN
0959-8049